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CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli emerged recently in Cameroon. CTX-M-15
was encoded by two different multiresistance plasmids, of which one carried an ISEcp1-blaCTX-M-15 element
flanked by a 5-bp target site duplication and inserted within a Tn2-derived sequence. A truncated form of this
element in the second plasmid was identified.
Extended-spectrum -lactamase (ESBL)-positive entero-
bacteria are frequently isolated in hospitals in Cameroon. Up
to 1999, SHV-12 and SHV-2a were the dominant ESBLs (J.
Gangoue-Pieboji, B. Bedenic, S. Koula-Shiro, et al., Program
Abstr. 9th Int. Congr. Infect. Dis., abstr. 15419, 2000). In a
PCR-based screening for bla types applied to enterobacteria
collected during July and August 2002 in Yaounde Central
Hospital, it was found that 14 out of 17 ESBL-positive isolates
produced SHV ESBLs, confirming previous findings. The re-
maining isolates (one Klebsiella pneumoniae isolate and two
Escherichia coli isolates), however, were blaCTX-M positive.
CTX-M is a rapidly growing family of ESBLs that preferen-
tially hydrolyze cefotaxime. The blaCTX-M genes are commonly
found in plasmids carried by enterobacteria. CTX-M ESBLs
have been reported worldwide, the highest prevalence being
observed in Latin America, Eastern Europe, and the Far East
(3, 16). We report here on the emergence of CTX-M produc-
ers also in Cameroon.
The three clinical isolates studied (K. pneumoniae YC-17
and E. coli YC-5b and YC-14) had been derived from patients
with urinary tract infection acquired during hospitalization.
The isolates were resistant to amoxicillin, amoxicillin-clavu-
lanate, piperacillin, cefotaxime, ceftazidime, cefepime, and az-
treonam, as determined by the agar dilution method. Activity
of cefotaxime and ceftazidime was restored by clavulanic acid.
MICs of piperacillin-tazobactam, cefoxitin, and imipenem
were within the susceptibility range. Isolates were also resistant
to various non--lactam antibiotics by a disk diffusion assay
(Table 1).
-Lactamases were extracted by ultrasonic treatment and
characterized by isoelectric focusing. Isolates produced -lac-
tamases with apparent isoelectric points (pIs) equal to 7.3 and
8.8. E. coli YC-5b produced an additional -lactamase focusing
at 5.4. Isolates were positive in a PCR specific for blaCTX-M-3-
related genes (6). Sequencing the PCR products showed 100%
homology with blaCTX-M-15 (accession no. AY044436) (6).
CTX-M-15 corresponded to the -lactamase with a pI of 8.8.
Also, by PCR with blaTEM- and blaOXA-specific primers (1, 15)
and the sequencing of the amplicons the -lactamases with pIs
of 7.3 and 5.4 were identified as OXA-30 and TEM-1. There-
fore, oxyimino--lactam resistance was mainly due to CTX-M-
15.
In conjugation experiments performed in liquid media E.
coli YC-14 and K. pneumoniae YC-17 transferred resistance to
oxyimino--lactams and aminoglycosides to an E. coli K-12
host (Table 1). Plasmid analysis indicated transfer of 90-kb
plasmids that produced similar PstI restriction patterns. Addi-
tionally, in both preparations, PstI fragments equal in size (5.3
kb) hybridized with a digoxigenin-labeled blaCTX-M-15 probe,
suggesting spread of a single plasmid (pYC-14). E. coli YC-5b
harbored a 50-kb plasmid (pYC-5b) that was used to transform
E. coli DH5. Transformants exhibited the resistance pheno-
type of E. coli YC-5b (Table 1). The PstI-generated restriction
pattern of pYC-5b was different from that of pYC-14. Hybrid-
ization of the blaCTX-M-15 probe occurred on a 3.4-kb PstI
fragment of pYC-5b. Isoelectric focusing and PCR experi-
ments showed that pYC-5b and pYC-14 coded also for the
penicillinases produced by the respective clinical isolates.
Plasmids pYC-5b and pYC-14 were partially digested with
Sau3A, and the fragments were ligated into pBCSK() (Strat-
agene). Recombinant plasmids were used to transform E. coli
DH5a. Selection was performed in media containing either
cefotaxime or ampicillin. Colony hybridization with a blaCTX-M
probe was also applied to facilitate selection. Nucleotide se-
quences of overlapping fragments were determined with an
ABI 377 sequencer (Applied Biosystems).
In pYC-5b, an ISEcpI insertion sequence, comprising an
intact tnpA gene and two 30-bp imperfect inverted repeats
(IRL and IRR) characteristic of this element (accession no.
AJ242809) (9), was located 48 bp upstream of blaCTX-M-15. The
promoter driving blaCTX-M transcription was identified within
the 3 noncoding sequence of ISEcpI (13). An 18-bp sequence
corresponding to the external part of IRR of ISEcpI (putative
IRR) was found 373 bp downstream of blaCTX-M-15. The in-
tervening 373-bp sequence had 55% homology with the respec-
tive chromosomal region of Kluyvera cryocrescens (from nucle-
otide [nt] 3304 to 3677 in the sequence with accession no.
AY026417) (4). The ISEcpI-blaCTX-M-15-containing sequence
was flanked by 5-bp direct repeats and inserted within tnpA
(tnpA1, 214 nt from the 5 end; tnpA2, 2,246 nt) of a Tn2-
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derived sequence. The latter also contained part of the respec-
tive tnpR (tnpR; 173 nt from the 5 end) and was flanked by
directly repeated IS26 elements (Fig. 1A). The truncated forms
of transposase and resolvase of Tn2 were, most likely, not
functional. A homologous segment, extending from the 3 end
of the tnpA gene of ISEcp1 up to the IS26 of the right end, was
carried by the self-transferable plasmid pYC-14. This sequence
was preceded by IS26 (Fig. 1B).
Since its first description in 2001, CTX-M-15 has been iden-
tified in multiple locations in Asia and Europe (2, 5–8, 10–12,
17). This study documents for the first time the emergence of
CTX-M-15-producing enterobacteria in an African country.
CTX-M-15 differs from CTX-M-3 by an Asp-2403Gly substi-
tution that increases activity against ceftazidime (14). The en-
hanced substrate spectrum of CTX-M-15 is probably a factor
contributing to its spread.
ISEcp1-like sequences have been associated with various
blaCTX-M genes of the three major evolutionary groups (3).
The presence of a 5-bp duplication at the boundaries of the
ISEcp1-blaCTX-M-15 element and the resemblance of its right
end to the IRR of ISEcp are indicative of transposition. Similar
sequence characteristics in the recently described ISEcp1B-
blaCTX-M-19 element led to the hypothesis that ISEcp1 medi-
ates a regular transposition process (13). However, the puta-
tive IRRs of these elements had less than 60% homology with
the corresponding region of IRR and also differ from each
other by 9 nt (50% homology). Therefore, the possibility for a
one-ended transposition mechanism cannot be definitely ex-
cluded (P. D. Stapleton, Abstr. 39th Intersci. Conf. Antimi-
crob. Agents Chemother., abstr. 1457, 1999).
Geographical and temporal clusters of identical blaCTX-M
genes carried by apparently different plasmids have also been
reported in previous studies (reviewed in reference 3). Nota-
bly, the sequence homology of the CTX-M-encoding loci in
pYC-5b and pYC-14 extends beyond ISEcpI-blaCTX-M-15, in-
cluding parts of the Tn2 flanking segments. Recently, Lartigue
et al. described plasmids carrying ISEcp1-blaCTX-M-15 elements
inserted within tnpA of a Tn2-like transposon harbored by E.
coli isolates from France and India (8). Furthermore, a Gen-
Bank search revealed a plasmid from E. coli isolated in Canada
(pC15-1a) that also contained a Tn2-inserted ISEcp1-blaCTX-M-15
(from nt 17077 to 23482 in the sequence with accession no.
FIG. 1. Schematic representation of the ISEcp1-blaCTX-M-15-containing sequences in plasmids pYC-5b (A) and pYC-14 (B). Inverted repeat
sequences (IR) and target site duplications (TSD) are shown. Arrows indicate direction of transcription. The thick line (B) denotes homology with
the sequence in panel A.
TABLE 1. Antibiotic susceptibility of CTX-M-15-producing strains
Strain
MICs (g/ml) ofa: Other
resistance
markersbAMX AMC PIP TZP FOX CTX CTX CAZ CAZ ATM FEP IMI
E. coli YC-14 256 32 256 32 8 256 0.5 32 1 64 64 0.25 Gm, Tb, Sul,
Tmp, Cm
E. coli K-12(pYC-14) 256 32 256 16 8 256 0.25 32 0.5 32 32 0.12 Gm, Tb
K. pneumoniae YC-17 256 64 256 32 16 256 1 128 2 128 128 0.5 Gm, Tb, Sul,
Tmp, Cm
E. coli K-12(pYC-17) 256 32 256 16 8 256 0.25 32 0.5 32 32 0.12 Gm, Tb
E. coli YC-5b 256 32 256 32 16 256 0.5 64 1 64 64 0.12 Gm, Tb, Sul,
Tmp
E. coli DH5(pYC-5b) 256 32 256 8 4 256 0.12 32 0.5 32 16 0.06 Gm, Tb, Sul,
Tmp
E. coli K-12 4 2 1 1 4 0.06 —c 0.25 — 0.06 0.06 0.06
E. coli DH5 2 2 1 1 4 0.06 — 0.12 — 0.06 0.06 0.06
a AMX, amoxicillin; AMC, amoxicillin-clavulanic acid (2:1); PIP, piperacillin; TZP, piperacillin plus tazobactam (4 g/ml); Fox, cefoxitin; Ctx, cefotaxime; CTX,
cefotaxime plus clavulanic acid (4 g/ml); CAZ, ceftazidime; CAZ, ceftazidime plus clavulanic acid (4 g/ml); ATM, aztreonam; IMI, imipenem.
b Gm, gentamicin; Tb, tobramycin; Sul, sulfonamides; Tmp, trimethoprim; Cm, chloramphenicol.
c —, not done.
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AY458016 [M. R. Mulvey et al., unpublished data]). This se-
quence was homologous to that found in pYC-5b except that it
lacked the left-hand IS26. Also, in silico restriction analysis of
pC15-1a indicated patterns different from that of pYC-5b. Since
ISEcp1 does not exhibit marked target site selectivity, it can be
hypothesized either that the CTX-M-15-encoding plasmids dis-
cussed here diverged from an ancestral ISEcp1-blaCTX-M-carrying
plasmid or that the ISEcp1-blaCTX-M-15 sequence was indepen-
dently acquired as part of a larger mobile element.
Nucleotide sequence accession numbers. The described se-
quences have been assigned GenBank accession numbers
AY604721 and AY604722.
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